Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogene amplification in pediatric brain tumors.

J C Wasson1, R L Saylors, P Zeltzer

  • 1Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

Cancer Research
|May 15, 1990
PubMed
Summary

Oncogene amplification is uncommon in pediatric brain tumors, particularly primary medulloblastomas. However, cell lines show greater amplification diversity, and pediatric glioblastoma may resemble adult forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.

Leukemia·2017
Same author

The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.

Oncogene·2017
Same author

Zebrafish models of leukemia.

Methods in cell biology·2017
Same author

Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.

Leukemia·2016
Same author

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.

Oncogene·2016
Same author

Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish.

Methods in cell biology·2016

Area of Science:

  • Neuro-oncology
  • Molecular genetics
  • Pediatric oncology

Background:

  • Limited data exists on molecular abnormalities in pediatric brain tumors compared to adult gliomas.
  • Understanding oncogene amplification is crucial for pediatric brain tumor classification and treatment.

Purpose of the Study:

  • To investigate oncogene amplification in various pediatric brain tumors.
  • To compare molecular findings in primary tumors versus tumor-derived cell lines.
  • To assess differences in oncogene amplification between pediatric and adult brain tumors.

Main Methods:

  • Analysis of DNA from 37 primary pediatric brain tumors and 4 cell lines.
  • Utilized probes for 11 known oncogenes (e.g., erbB1, myc, ras, N-myc).
  • Examined medulloblastomas, glial tumors, meningioma, ependymomas, and primitive neuroectodermal tumors.

Related Experiment Videos

Main Results:

  • Oncogene amplification was rare in primary pediatric brain tumors (1/20 medulloblastomas, 1/12 glial tumors).
  • Medulloblastoma cell lines showed higher amplification frequency and diversity (erbB1, c-myc, N-myc).
  • Pediatric glioblastoma multiforme showed erbB1 amplification, similar to adult cases.

Conclusions:

  • Oncogene amplification is an uncommon activation mechanism in pediatric brain tumors.
  • Tumor-derived cell lines may exhibit greater molecular heterogeneity than primary tumors.
  • Findings suggest molecular differences between pediatric glial tumors and adult counterparts, except possibly glioblastoma multiforme.